WeGuide vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
WeGuide compared with ArteraAI
| Detail | 
WeGuide | 
ArteraAI |
|---|
| What it does | Patient management platform for clinical trials and healthcare research
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Established
| Not given
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | AU
| US
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - eScreening with automated eligibility checks
- Electronic consent with interactive digital forms
- Form builder with rich question types
- Patient-reported outcomes and clinical outcome assessments
- Wearable device integration including Garmin
- Integration engine for EHR, PAS, EDC systems
- Analytics dashboards
- White-label app deployment
- Telehealth capabilities
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - Platform deployment in weeks with changes made in minutes
- 94% patient adherence rates
- 10x cost savings compared to traditional solutions
- Saves researchers 9 months and $450,000 per project
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 31 ▼ −1 (down) since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 23 | 15 |
|---|
| Citation Flow (Majestic) | 32 | 27 |
|---|
| Referring domains (Majestic) | 279 | 285 |
|---|
5 details filled in for both companies.
More alternatives to WeGuide More alternatives to ArteraAI